Skip to main content
IMAGION BIOSYSTEMS LIMITED logo

IMAGION BIOSYSTEMS LIMITED — Investor Relations & Filings

Ticker · IBX ISIN · AU000000IBX6 ASX Professional, scientific and technical activities
Open in API
Filings indexed 659 across all filing types
Latest filing 2021-12-15 Investor Presentation
Country AU Australia
Listing ASX IBX

About IMAGION BIOSYSTEMS LIMITED

https://imagionbiosystems.com/

Imagion Biosystems Limited is a medical technology company specializing in the development of advanced diagnostic imaging solutions. The company's proprietary MagSense technology utilizes superparamagnetic iron oxide nanoparticles to detect specific cancer cells non-invasively. By functionalizing these nanoparticles with targeting antibodies, the system can identify the presence and location of malignancies, such as HER2-positive breast cancer, using highly sensitive magnetic sensors. This approach aims to provide a safer, more accurate alternative to traditional biopsy and imaging methods by eliminating the need for ionizing radiation or radioactive tracers. The technology is designed to improve clinical decision-making through earlier detection and better staging of diseases, ultimately enhancing patient outcomes in oncology.

Recent filings

Filing Released Lang Actions
Imagion Biosystems December 2021 Investor Newsletter 8 pages 1.3MB
Investor Presentation Classification · 90% confidence The document is titled 'Imagion Biosystems December 2021 Investor Newsletter' and contains a message from the CEO, updates on company activities, clinical study progress, new patents, and operational changes. It is a newsletter format providing general company updates and investor communications rather than a formal financial report or regulatory filing. There are no detailed financial statements, audit information, or regulatory disclosures typical of Annual Reports, Interim Reports, or Regulatory Filings. The document is over 11,000 characters, indicating it is a substantive newsletter rather than a brief announcement. Therefore, the best fitting category is Investor Presentation (IP), as it is a detailed presentation for investors focusing on company developments, strategy, and market position, albeit in newsletter form rather than a slide deck.
2021-12-15 English
Cleansing Notice under Section 708A 1 page 137.1KB
Regulatory Filings Classification · 95% confidence The document is a notice pursuant to Section 708A(5)(e) of the Corporations Act 2001, indicating the issuance of shares without a disclosure document due to shareholders exercising options. It is a regulatory announcement about share issuance and compliance with disclosure requirements under the Corporations Act. The document is short (2087 characters) and does not contain financial statements or detailed financial data. It is not an annual report, earnings release, or capital/financing update per se, but a formal regulatory notice about share issuance under specific legal provisions. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-12-01 English
Application for quotation of securities - IBX 15 pages 241.7KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance of securities due to options being exercised or convertible securities being converted. The document is a regulatory announcement related to capital markets and securities listing, not a financial report, earnings release, or management discussion. It is a formal filing to the exchange to notify about new securities quotation. This fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and securities issuance.
2021-12-01 English
IBXO Options Exercise Complete 1 page 89.8KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 2 December 2021 from Imagion Biosystems Limited regarding the completion of the exercise of listed options (IBXO). It mentions the receipt of funds from option exercises, references an Appendix 2A filing, and a cleansing statement under the Corporations Act. The content focuses on a capital raising event through option exercises and does not contain financial statements or detailed financial analysis. The document length is 2278 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this is best classified as a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing.
2021-12-01 English
Cleansing Notice under Section 708A 1 page 137.1KB
Regulatory Filings Classification · 95% confidence The document is a notice pursuant to Section 708A(5)(e) of the Corporations Act 2001, indicating the issuance of shares without a disclosure document due to shareholders exercising options. It is a regulatory announcement about share issuance and compliance with disclosure requirements under the Corporations Act. The document is short (2089 characters) and does not contain financial statements or detailed financial data. It is not an annual report, earnings release, or capital/financing update per se, but a formal regulatory notice about share issuance under specific legal provisions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-25 English
Application for quotation of securities - IBX 15 pages 241.7KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance of securities due to options being exercised or convertible securities being converted. The document is a formal announcement to the exchange regarding the quotation of new securities, not a financial report or earnings release. It is regulatory in nature, related to capital markets and securities listing requirements. This type of document fits best under the category of Capital/Financing Update (CAP), as it concerns updates on the company's capital structure and securities issuance.
2021-11-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.